Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 35826 - 35850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Doxorubicin	Approved Investigational	BCL2	596	downregulated	Doxorubicin results in decreased expression of BCL2 mRNA	18q21.33	A22438 A21894 A22196 A22420 A22439 A22435
Doxorubicin	Approved Investigational	BCL2	596	upregulated	Doxorubicin results in increased expression of BCL2 mRNA	18q21.33	A22427 A22432 A22440
Doxorubicin	Approved Investigational	BCL2L1	598	downregulated	Doxorubicin results in decreased expression of BCL2L1 mRNA	20q11.21	A22439 A22218 A22431
Doxorubicin	Approved Investigational	BCL2L1	598	upregulated	Doxorubicin results in increased expression of BCL2L1 mRNA	20q11.21	A22427 A22420
Doxorubicin	Approved Investigational	BCL2L12	83596	downregulated	Doxorubicin results in decreased expression of BCL2L12 mRNA	19q13.33	A22196 A22434
Doxorubicin	Approved Investigational	BCL2L12	83596	upregulated	Doxorubicin results in increased expression of BCL2L12 mRNA	19q13.33	A22194
Doxorubicin	Approved Investigational	BID	637	downregulated	Doxorubicin results in decreased expression of BID mRNA	22q11.21	A22441
Doxorubicin	Approved Investigational	BIK	638	downregulated	Doxorubicin results in decreased expression of BIK mRNA	22q13.2	A22441
Doxorubicin	Approved Investigational	BIRC2	329	upregulated	Doxorubicin results in increased expression of BIRC2 mRNA	11q22.2	A22442 A22439
Doxorubicin	Approved Investigational	BIRC3	330	downregulated	Doxorubicin results in decreased expression of BIRC3 mRNA	11q22.2	A22443
Doxorubicin	Approved Investigational	BIRC3	330	upregulated	Doxorubicin results in increased expression of BIRC3 mRNA	11q22.2	A22441 A22442
Doxorubicin	Approved Investigational	BIRC5	332	downregulated	Doxorubicin results in decreased expression of BIRC5 mRNA	17q25.3	A22227 A22444 A22445 A22439
Doxorubicin	Approved Investigational	BIRC5	332	upregulated	Doxorubicin results in increased expression of BIRC5 mRNA	17q25.3	A22446 A22442
Doxorubicin	Approved Investigational	BIRC6	57448	upregulated	Doxorubicin results in increased expression of BIRC6 mRNA	2p22.3	A22442
Doxorubicin	Approved Investigational	BIRC7	79444	upregulated	Doxorubicin results in increased expression of BIRC7 mRNA	20q13.33	A22442
Doxorubicin	Approved Investigational	BIRC8	112401	upregulated	Doxorubicin results in increased expression of BIRC8 mRNA	19q13.42	A22442
Doxorubicin	Approved Investigational	BMP4	652	downregulated	Doxorubicin results in decreased expression of BMP4 mRNA	14q22.2	A22218
Doxorubicin	Approved Investigational	BNIP3	664	downregulated	Doxorubicin results in decreased expression of BNIP3 mRNA	10q26.3	A22447
Doxorubicin	Approved Investigational	BRCA1	672	downregulated	Doxorubicin results in decreased expression of BRCA1 mRNA	17q21.31	A21498 A22448 A22449
Doxorubicin	Approved Investigational	BRCA2	675	downregulated	Doxorubicin results in decreased expression of BRCA2 mRNA	13q13.1	A21498
Doxorubicin	Approved Investigational	BTG2	7832	upregulated	Doxorubicin results in increased expression of BTG2 mRNA	1q32.1	A22441
Doxorubicin	Approved Investigational	CA9	768	downregulated	Doxorubicin results in decreased expression of CA9 mRNA	9p13.3	A22447
Doxorubicin	Approved Investigational	CACNA1G	8913	downregulated	Doxorubicin results in decreased expression of CACNA1G mRNA	17q21.33	A21904
Doxorubicin	Approved Investigational	CACNA2D2	9254	downregulated	Doxorubicin results in decreased expression of CACNA2D2 mRNA	3p21.31	A21904
Doxorubicin	Approved Investigational	CAPN6	827	downregulated	Doxorubicin results in decreased expression of CAPN6 mRNA	Xq23	A22426

Displaying entries 35826 - 35850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability